Previous work has shown that orthostatic hypotension associated with cardiovascular deconditioning results from inadequate peripheral vasoconstriction. Using the hindlimb-unloaded (HU) rat as a model to induce cardiovascular deconditioning, the purpose of this study was to test the hypothesis that 14 days of HU diminishes vasoconstrictor responsiveness of mesenteric resistance arteries. Mesenteric resistance arteries from control (n = 43) and HU (n = 44) rats were isolated, cannulated and However, vasoconstrictor responses to KCl, NE, and caffeine were diminished by HU, as well as the rate of constriction to NE (C, 14.8 ± 3.6 µm/s vs. HU 7.6 ± 1.8 µm/s).
Introduction
Following exposure to weightlessness, many astronauts experience post-flight orthostatic hypotension (6, 52) due, in part, to a diminished ability of the cardiovascular system to rapidly elevate peripheral vascular resistance (PVR) ( Therefore, evidence suggests end-organ responsiveness to vasoconstrictor stimuli is diminished in humans following microgravity and bedrest deconditioning. In addition, orthostatic intolerance may reflect the relative inability of arteries to rapidly vasoconstrict.
Specifically, a reduced rate of arterial constriction in modulating PVR in response to an orthostatic challenge could contribute to a compromised ability to precisely regulate mean arterial pressure.
The tail-suspended hindlimb unloaded (HU) rat simulates a weightless environment and bedrest deconditioning through the mechanical unloading of the hindlimb bones and muscles and the associated cephalic fluid shift (17, 55 ). HU rats demonstrate many cardiovascular adaptations characteristic of cardiovascular deconditioning in humans, including a reduced exercise capacity (17, 39) , orthostatic hypotension (29, 55), Page 3 of 38 and a diminished capacity to elevate PVR (31, 57). This diminished ability to elevate PVR has been shown to be related to reductions in vasoconstrictor responsiveness of a number of conduit arterial segments (14, 16, 40, 41, 43, 59 ) and skeletal muscle arterioles (13) from HU rats. However, because 20% of the increase in PVR during orthostasis normally occurs as a result of vasoconstriction in splanchnic organs (42), a diminished constrictor response within the splanchnic vasculature could potentially be an underlying mechanism for orthostatic hypotension. Results demonstrating diminished vasoconstrictor responses of mesenteric arteries to elevations in transmural pressure (28) and norepinephrine (NE) (5, 38) have been reported in HU rats. However, to date there have been no investigations which determine whether the rate of arterial vasoconstriction is altered by HU, only whether the magnitude and sensitivity of vasoconstriction is affected. Therefore, the purpose of the present study was to 1) determine whether HU diminishes the rate of vasoconstriction of mesenteric arteries to NE, and 2) examine vasoconstrictor responses working through a variety of cell signaling pathways (i.e., myogenic, NE, KCl and caffeine) to determine a possible mechanism for the reported decrement in mesenteric vasoconstriction with HU and whether it is related to a diminished sarcoplasmic reticulum intracellular Ca 2+ release mechanism. We hypothesized that 14 days of HU would diminish the rate of mesenteric artery vasoconstriction, as well as reduce the vasoconstrictor response to each protocol tested.
Materials and Methods
All procedures performed in this study were approved by the Texas A&M and West
Virginia University Animal Care Committees and conformed to the National Institutes of 
Microvessel Preparation
Under a dissecting microscope, distal arcading resistance arteries of the mesentery ( 200 µm), immediately proximal to the transmural arterioles, were identified, dissected free from surrounding tissue, transferred to a Lucite vessel chamber containing PSS-albumin solution (pH 7.4), and cannulated as previously described (5). The mesenteric artery segments were then pressurized at 108 cm H 2 O, which corresponds to in vivo arterial pressures for these vessels (21) . The vessels were allowed to equilibrate for 1 hour at 37 o C before intrinsic vasomotor properties were characterized. Internal diameters were measured continuously throughout the experiment using the video recorder.
Experimental Design

Protocol I: Myogenic Vasoconstrictor Responses
Active myogenic responsiveness to step changes in intralumenal pressure was characterized in the initial group of mesenteric arteries. Following the equilibration period at baseline pressures, intralumenal pressure was incrementally increased from 110 to 180 cm H 2 O by 10 cm H 2 O, reduced incrementally to 30 cm H 2 O, and finally increased back up to baseline pressure in 10 cm H 2 O increments. Intralumenal pressure and vessel diameter were recorded continuously for 5 minutes following each incremental change in pressure.
A passive pressure-diameter relation was then established by filling the vessel chamber with calcium-free PSS containing 2.0 mM EDTA. The calcium-free PSS was replaced every fifteen minutes over a 60 minute period to facilitate relaxation of the vascular smooth muscle prior to determining the passive pressure-diameter relation. The intralumenal pressure was then incrementally changed as describe above. Diameter was continuously recorded for 3 minutes following each pressure change. Results from the active myogenic response indicated that when intralumenal pressure was elevated from baseline up to 180 cm H 2 O there was no difference in the arterial response between control and HU rats ( Fig   1A) , when pressure was lowered to 30 cm H 2 O there was no difference (Fig 1B) , but when it was raised from 30 cm H 2 O back to baseline intralumenal pressure the myogenic vasoconstriction was less in arteries from HU rats (Fig 1C) . This result was surprising,
given that one might have expected that differences in vasoconstriction would be most evident at the highest pressures. Thus, we sought to determine whether this difference in the myogenic response was the result of one of several possible factors; 1) that the vessels from HU rats had become less viable at the end of a rather prolonged test protocol, or 2)
whether the exposure to a low intralumenal pressure might have somehow triggered the different response. Therefore, a second series of studies were performed that were of the same duration as the first series, but the pressure was not lowered to sub-physiological levels. In this second series, intralumenal pressure was set at 108 cm H 2 O, and then intralumenal pressure was increased by 10 cm H 2 O increments up to 180 cm H 2 O and incrementally reduced to 100 cm H 2 O. Intralumenal pressure was then maintained at 100 cm H 2 O for a period of 85 minutes, which was then followed by a pressure increase to 110 cm H 2 O. Thus, the duration of this test corresponded to the duration of the previous myogenic response, the only difference being that this pressure-response relation did not expose the mesenteric arteries to an intraluminal pressure lower than 100 cm H 2 O.
Lumenal diameter was continuously recorded for five minutes following each pressure change, and during the maintenance period at 100 cm H 2 O.
Protocol II: KCl and Norepinephrine Mediated Vasoconstriction
Concentration-diameter responses to potassium chloride (KCl), which mediates vasoconstriction through voltage-gated Ca 2+ channels, and norepinephrine (NE), which mediates vasoconstriction through -adrenergic receptors, were determined in a third 
where Diameter (t) is the change in diameter at time t, Diameter (b) is baseline diameter, 
Protocol V: mRNA and Protein Expression
Mesenteric artery segments from animals used in the above four protocols and of similar arterial size to those used for in vitro experimentation were isolated, snap frozen and stored at -80°C for mRNA and protein expression as previously described (18, 47) .
Briefly, for mRNA expression arteries were pulverized in lysate buffer and total RNA was extracted with the RNAqueous filter system (Ambion). Total RNA was used to perform real-time PCR with TaqMan Pre-Developed Assay Reagents to quantitatively determine sarcoplasmic reticulum Ca 2+ ATPase 2 (product number Rn0144235_g1), ryanodine 1 receptor (RyR1) (product number Rn01545053_gH), ryanodine 2 receptor (RyR2) (product number Rn01470310_mH), and ryanodine 3 receptor (RyR3) (product number Rn01485062_mH) mRNA expression (ABI Prism 7700 Sequence Detection system).
Based on results from mRNA analyses, RyR2 protein expression in mesenteric resistance arteries was determined. For western blot analysis of RyR2 protein expression, mesenteric artery segments were homogenized in lyses buffer (5 min at 4°C) containing 40
15 mM MgCl 2 , 115 mM NaCl, 1 mM Na-orthovanadate, 1 mM NaF, 2.5 mM urea, 0.25% deoxycholate, 10% glycerol, 1% NP-40, 0.2% SDS, and 1:50 mammalian protease inhibitor cocktail (Sigma, St. Louis, MO). Equal amounts of sample protein (10 µg total protein per sample) were separated on a 4-20% gradient polyacrylamide gel and transferred to a nitrocellulose membrane. The membranes were divided at the ladder 117 kDa band and exposed to either monoclonal RyR2 antibody (anti-mouse, 2 µg/ml; Calbiochem, San Diego, CA) or glyceraldehyde dehydrogenase (GAPDH) antibody (anti-mouse, 1 µg/ml; Chemicon Labs, Temecula, CA). Alexa Fluor 680 goat anti-mouse
(1:10,000 dilution; Molecular Probes) was used to fluorescently label the RyR2 and GAPDH antibodies. The density of signals specific for the RyR2 and GAPDH bands in a given lane on a membrane was measured after the membrane was scanned with an Odyssey infrared imaging system (Li-COR Biosciences, Lincoln, NE).
Solutions and Drugs
The PSS buffer contained (in mM) 145 NaCl, 4. 
Statistical Analysis
Intralumenal diameters were measured throughout the duration of each experimental protocol. At the end of each experiment the vessel was placed in Ca 2+ -free bathing solution and rinsed several times over the course of an hour to obtain a maximal diameter. The development of spontaneous tone was expressed as the percent constriction relative to maximal diameter as previously described (13, 35) . Pressure-response and concentration-response curves were expressed as intralumenal diameter (µm) and evaluated using repeated-measures analysis of variance with one within (intralumenal pressure or concentration) and one between (experimental groups) factor. Planned contrasts were conducted at each intralumenal pressure or concentration level to determine whether differences exist between experimental groups (control vs. HU). To detect differences in sensitivity to vasoconstrictors, EC 50 values were designated as the concentration of each substance producing 50% of its maximal response. Student's unpaired t-test was used to determine whether differences in body mass, soleus muscle mass, soleus muscle-to-body weight ratio, developed spontaneous tone, maximal diameter, and EC 50 values were significant. For vasoconstriction dynamics (i.e., Protocol IV), luminal diameters and the resultant model parameters within and between groups were analyzed by means of a one-way analysis of variance. Individual significant differences were examined post-hoc using the Tukey test. All values are presented as means ± standard error. A value of P < 0.05 was required for significance.
Results
Soleus muscle-to-body mass ratio
The body mass of HU rats (430 ± 14 g) was lower than that of control rats (472 ± 17 g). Soleus muscle mass was 42% lower (127 ± 5 mg) following HU when compared to control (222 ± 6 mg). Similarly, HU resulted in a 35% reduction in the soleus muscle-to-body mass ratio (control, 0.46 ± 0.01 mg/g vs. HU, 0.30 ± 0.01 mg/g; P<0.05).
Soleus muscle atrophy, which is characteristic of reduced hindlimb skeletal muscle weight bearing activity, confirms the efficacy of the HU treatment.
Vessel characteristics
The maximal intralumenal diameter (determined in Ca 2+ -free solution) of mesenteric resistance arteries did not differ between control (237 ± 16 µm) and HU (253 ± 6 µm) rats. Likewise, HU had no effect on the development of spontaneous tone (control, 42 ± 2 %; HU, 33 ± 5 %).
Myogenic Response
Hindlimb unloading had no effect on myogenic responses to pressure increases from 108 to 180 cmH 2 O (Fig 1A) , or to reductions in pressure from 180 to 30 cmH 2 O ( Fig   1B) . However, myogenic responses to pressure increases from 30 to 110 cmH 2 O were less in mesenteric arterioles from HU rats when compared to those of control vessels (Fig 1C) .
Myogenic properties of mesenteric arteries exposed to the second pressure response protocol, i.e., those not exposed to intralumenal pressures below 100 cmH 2 O, were not affected by HU (Fig 2A) . The findings of the active myogenic response did not differ when the data were analyzed as actual diameters, as shown in the figures, or as a percent constriction. Hindlimb unloading had no effect on passive pressure-response characteristics ( Fig 2B) .
Responses to NE, KCl and Caffeine
Increases in NE and KCl concentration produced dose-dependent decreases in intralumenal diameter in mesenteric arteries. Both the maximal response and the sensitivity (EC 50 ) of mesenteric arteries to NE were significantly diminished following HU (Fig 3A) . Vasoconstrictor responsiveness to KCl was lower in mesenteric arteries from HU rats ( Fig 3B) ; the maximal vasoconstrictor response to KCl was reduced by HU, while sensitivity was not altered. Vasoconstrictor responses to caffeine were lower in mesenteric arteries from HU rats (Fig 4) . These findings with NE, KCl and caffeine did not differ regardless of whether the data are expressed as actual diameters or as a percent constriction.
Vasoconstriction Dynamics
The model chosen (i.e., delay followed by exponential) provided a superb fit to the data evidenced by the low 2 values (control, 28.9 ± 6.1; HU, 45.6 ± 8.3) and high correlation coefficient (control, r = 0.978 ± 0.028; HU, 0.958 ± 0.019). Neither the initial diameter nor maximal diameter was different between groups ( Table 1) . As demonstrated in Figure 5 , upon exposure to 10 -4 M NE, mesenteric arteries from both groups displayed a short latent period (time-delay) where lumen diameter did not change, followed by a mono-exponential decline to a steady lumen diameter, with a marked blunting in the dynamics of vasoconstriction in HU. The time-delay (TD) preceding the monoexponential decline from HU mesenteric arteries was over twice as long versus control (Table 1) (Fig 6B) . HU also demonstrated a smaller magnitude of luminal diameter change to NE ( , control, 132 ± 25 µm vs. HU, 74 ± 15 µm; P<0.05; consistent with a reduced sensitivity and maximal response as discussed above), which, when coupled with the slower time constant, result in a reduced rate of contraction in arteries from HU rats (Fig 6A) .
mRNA and Protein Expression
Sarcoplasmic reticulum Ca 2+ ATPase 2 (control, 12 ± 3 Ca 2+ ATPase 2:18s; HU, 15 ± 3 ATPase 2:18s) and RyR3 (control, 10 ± 3 RyR3:18s; HU, 20 ± 10 RyR3:18s) mRNA expression did not differ between groups, while no mRNA expression for RyR1 was detected in mesenteric arteries for either group (control, n = 10; HU, n = 12). In contrast, both RyR2 mRNA (Fig 7) and protein (Fig 8) expression were lower in mesenteric arteries from HU rats.
Discussion
The purpose of this study was to determine whether hindlimb unloading alters the Hindlimb unloading reduced the vasoconstrictor response of mesenteric arteries to caffeine (Fig. 4) . Previous work has shown that Ca 2+ release from the sarcoplasmic reticulum occurs in response to increasing concentrations of NE, KCl and caffeine (7, 10, 48). Any alteration in the ryanodine receptor function -Ca 2+ release mechanisms from the sarcoplasmic reticulum could consequently alter contractile responsiveness of arterial smooth muscle cells to these agonists. The reductions in caffeine-induced vasoconstriction (Fig. 4) The myogenic vasoconstrictor results of this present study (Fig 1C) corroborate those of Looft-Wilson and Gisolfi (28), who report diminished myogenic properties in mesenteric arteries isolated from hindlimb unloaded rats, despite several differences in the study design. For example, Looft-Wilson and Gisolfi (28) exposed animals to hindlimb unloading for 28 days, while animals in this present study were unloaded for a period of 14 days, and the pressure-diameter relation was evaluated in the presence of phenylephrine when arterioles failed to develop spontaneous tone, which was not done in the current study. Mesenteric arteries in this present study were exposed to a comparable range of pressures as used by Looft-Wilson and Gisolfi (28), however, the pressure in the present study began at that measured in vivo (108 cm H 2 O or 80 mmHg) and was incrementally elevated to 180 cm H 2 O, lowered to 30 cm H 2 O and then elevated back to an in vivo pressure (Fig. 1) . There was no difference in myogenic responsiveness between HU arteries and controls within the physiological range of pressures (Figs. 1A and 1B) .
However, only after the arteries were exposed to low pressures was a difference between groups apparent at the higher pressures (Fig. 1C) , as was also the case for Looft-Wilson and Gisolfi (28). To control for the possibility that the difference in myogenic constriction occurred at the end of a prolonged pressure-diameter response protocol, another time-matched study was performed that did not expose the vessel to low pressures. In this study, there were no differences in myogenic responses between groups ( Fig. 2A) . These data suggest that myogenic autoregulation within the physiological range of pressures is not altered by HU in mesenteric resistance arteries. Only when the arteries are exposed to low intralumenal pressures does a difference between groups become apparent. The reasons(s) underlying this phenomenon remains to be determined, but may be related to mobilization of extracellular vs. intracellular Ca 2+ at lower and higher transmural pressures.
It is currently believed that myogenic constriction in response to increased intralumenal pressure is initiated by vascular smooth muscle membrane depolarization, which then permits extracellular Ca 2+ entry through voltage-gated Ca 2+ channels (12, 32).
The dependence on extracellular Ca 2+ for contraction and myogenic tone in isolated skeletal muscle (19, 49) Together these studies indicate that the diminished aerobic capacity associated with hindlimb unloading is due in part to an impaired ability to elevate visceral vascular resistance and thus redistribute blood flow and O 2 to the active musculature.
The stimulus for the change in mesenteric artery vasoconstrictor responsiveness with hindlimb unloading is presently unknown. Direct measures of blood flow (31) and the lack of change in vascular structure (22, 28, 56) indicate that neither blood flow nor arterial pressure are significantly altered when rats are in an unloaded position. It has recently been suggested that decrements in peripheral artery vasoconstrictor responsiveness may be associated with a circulating systemic factor(s) that is altered during unloading (5).
Several circulating factors, such as atrial and brain natriuretic peptides, have been proposed (5) as mediators of the hyporesponsiveness to vasoconstrictor stimuli in the peripheral circulation.
Perspectives and Significance. The purpose of the present study was to determine whether unloading-induced deconditioning alters the intrinsic vasomotor properties of mesenteric resistance arteries, and in particular the rate of constriction, and to determine possible mechanisms for the reported decrements in mesenteric artery vasoconstriction.
These data demonstrate that hindlimb unloading diminishes the vasoconstrictor responsiveness of mesenteric arteries to NE (Fig. 3A) , KCl ( Fig 3B) and caffeine (Fig 4) , but does not affect myogenic vasoconstriction within a physiological range of pressures (Fig 2A) . The reduced vasoconstrictor response to caffeine along with the lower RyR2 
